Shin Yi Jang1, Darae Kim1, Jin-Oh Choi1, Eun-Seok Jeon1. 1. Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract
Background and Objectives: We sought to assess incidence, cause of death, and survival for amyloidosis. We acquired amyloidosis data from the National Health Insurance Service in Korea from 2006 through 2017 (n=2,233; male 53.5%). Methods: We calculated the age-standardized incidence rate, analyzed the survival rate (SR) using the Kaplan-Meier method, and analyzed the death risk using Cox proportional hazards methods. Results: The mean age was 57.0±16.7 years in males and 56.8±15.6 years in females (p=0.795). The proportion of death was 34.7%. The causes of death were endocrine, nutritional, and metabolic diseases (33.9%), malignant neoplasm (20.8%), and diseases of the circulatory system (9.68%). The overall age-standardized incidence rate was 0.47 persons per 100,000 persons in 2017. Overall, the 10-year SR for amyloidosis was 57.7%. Adjusted hazard ratios were 9.16 among 40s', 16.1 among 50s', 30.3 among 60s', 48.7 among 70s', 80.1 among people 80 years or older, and 1.21 in the medium-level socioeconomic position group. Conclusions: The age-standardized incidence rate of amyloidosis was about 0.5 persons per 100,000 persons in 2017. The 10-year SR of amyloidosis was about 58%. The most common cause of death was endocrine, nutritional, and metabolic diseases. The risk of death from amyloidosis increased with age and medium socioeconomic position.
Background and Objectives: We sought to assess incidence, cause of death, and survival for amyloidosis. We acquired amyloidosis data from the National Health Insurance Service in Korea from 2006 through 2017 (n=2,233; male 53.5%). Methods: We calculated the age-standardized incidence rate, analyzed the survival rate (SR) using the Kaplan-Meier method, and analyzed the death risk using Cox proportional hazards methods. Results: The mean age was 57.0±16.7 years in males and 56.8±15.6 years in females (p=0.795). The proportion of death was 34.7%. The causes of death were endocrine, nutritional, and metabolic diseases (33.9%), malignant neoplasm (20.8%), and diseases of the circulatory system (9.68%). The overall age-standardized incidence rate was 0.47 persons per 100,000 persons in 2017. Overall, the 10-year SR for amyloidosis was 57.7%. Adjusted hazard ratios were 9.16 among 40s', 16.1 among 50s', 30.3 among 60s', 48.7 among 70s', 80.1 among people 80 years or older, and 1.21 in the medium-level socioeconomic position group. Conclusions: The age-standardized incidence rate of amyloidosis was about 0.5 persons per 100,000 persons in 2017. The 10-year SR of amyloidosis was about 58%. The most common cause of death was endocrine, nutritional, and metabolic diseases. The risk of death from amyloidosis increased with age and medium socioeconomic position.
Authors: A Carla Zomer; Cuno S P M Uiterwaal; Enno T van der Velde; Jan G P Tijssen; Edwin C M Mariman; Carianne L Verheugt; Ilonca Vaartjes; Petronella G Pieper; Folkert J Meijboom; Diederick E Grobbee; Barbara J M Mulder Journal: Int J Cardiol Date: 2010-08-01 Impact factor: 4.164
Authors: S Parmar; P Kongtim; R Champlin; Y Dinh; Y Elgharably; M Wang; Q Bashir; J J Shah; N Shah; U Popat; S A Giralt; R Z Orlowski; M H Qazilbash Journal: Bone Marrow Transplant Date: 2014-06-02 Impact factor: 5.483
Authors: Brendan Wisniowski; Donald S A McLeod; Rebecca Adams; Yasmin Harvey; Ian Brown; Lloyd McGuire; Jane Armes; Peter Mollee Journal: Br J Haematol Date: 2019-05-31 Impact factor: 6.998
Authors: Shin Yi Jang; Eun-Young Ju; Su Ra Seo; Ji Yeon Choi; Sung-Ji Park; Duk-Kyung Kim; Seung Woo Park Journal: Int J Cardiol Date: 2014-04-18 Impact factor: 4.164
Authors: Surbhi Sidana; M Hasib Sidiqi; Angela Dispenzieri; Francis K Buadi; Martha Q Lacy; Eli Muchtar; David Dingli; Suzanne R Hayman; Wilson I Gonsalves; Prashant Kapoor; Nelson Leung; Rahma Warsame; Taxiarchis V Kourelis; Robert C Wolf; William J Hogan; Shaji K Kumar; Morie A Gertz Journal: Am J Hematol Date: 2019-07-11 Impact factor: 10.047